Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · July 12, 2023

Efficacy of Tezepelumab in Patients With Severe Uncontrolled Asthma

American Journal of Respiratory and Critical Care Medicine


Additional Info

American Journal of Respiratory and Critical Care Medicine
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials
Am J Respir Crit Care Med 2023 Jul 01;208(1)13-24, J Corren, A Menzies-Gow, G Chupp, E Israel, S Korn, B Cook, CS Ambrose, Å Hellqvist, SL Roseti, NA Molfino, JP Llanos, N Martin, K Bowen, JM Griffiths, JR Parnes, G Colice

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading